Zobrazeno 1 - 10
of 345
pro vyhledávání: '"N. Maniadakis"'
Publikováno v:
BMC Health Services Research, Vol 17, Iss 1, Pp 1-17 (2017)
Abstract Background Rapidly evolving socioeconomic and technological trends make it challenging to improve access, effectiveness and efficiency in the use of pharmaceuticals. This paper identifies and systematically classifies the prevailing pharmace
Externí odkaz:
https://doaj.org/article/9f17acae79a740e6bab42f7b7cc867fa
Publikováno v:
Applied Health Economics and Health Policy
Policy makers in countries, aiming to build and expand their healthcare systems and coverage, need effective procedures to support the most efficient use of limited financial resources. Tendering is commonly deployed to minimize and fix the purchasin
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Cancer Policy. 13:11-17
Aim To conduct an economic evaluation comparing Herceptin subcutaneous formulation (Herceptin-SC) with Herceptin intravenous formulation (Herceptin-IV), in the treatment of patients with human epidermal growth factor receptor 2-positive (HER2+) early
Publikováno v:
BMC Health Services Research, Vol 17, Iss 1, Pp 1-17 (2017)
BMC Health Services Research
BMC Health Services Research
Background Rapidly evolving socioeconomic and technological trends make it challenging to improve access, effectiveness and efficiency in the use of pharmaceuticals. This paper identifies and systematically classifies the prevailing pharmaceutical po
Following a national law introduced in 2017 in Thailand, the selection of winning bidders for multisourced pharmaceuticals and medical supplies in public hospitals must reflect "price-performance" aligned with the principles of worthiness, transparen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fbd5ddb5d32b350fa5c76b859a64a28
http://www.intechopen.com/articles/show/title/weighing-price-and-performance-for-decisions-for-multisource-pharmaceutical-bidding-in-public-hospit
http://www.intechopen.com/articles/show/title/weighing-price-and-performance-for-decisions-for-multisource-pharmaceutical-bidding-in-public-hospit
References by country. List of the references used to evaluate pharmaceutical policies in the countries considered. (DOCX 36Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45fe7d723b244815492d5389b9f61f79
Policies applied per country and policy domain. List of the tables with pharmaceutical policies used in each policy domain in the countries considered. (DOCX 62Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7def43837bdb14ccc8ed1032c4626757
Autor:
A. Goules, N. Maniadakis, Georgia Kourlaba, C. Tzanetakos, A. Tzioufas, P. Christou, T. Theodoratou
Publikováno v:
Rheumatology international. 37(9)
We aimed to evaluate the cost-effectiveness of certolizumab pegol (CZP), a pegylated fc-free anti-TNF, as add-on therapy to methotrexate (MTX) versus etanercept, adalimumab, or golimumab in patients with moderate-to-severe active rheumatoid arthritis
Publikováno v:
International Journal of Cardiology. 168:5336-5343
article i nfo Background: This study aims to develop a methodological framework for the comparative economic evaluation between Minimal Extracorporeal Circulation (MECC) versus conventional Extracorporeal Circulation (CECC) in patients undergoing cor